论文部分内容阅读
近日,瑞士制药巨头罗氏宣布,一款检测难辨梭状芽胞杆菌的试剂盒cobas Cdiff Test以及一款检测单纯疱疹病毒(HSV-1,HSV-2)的试剂盒cobas HSV-1&HSV-2 Test获得了FDA的510(k)批准。这2款试剂盒运行于罗氏cobas 4800系统,能够灵活用于性传播感染、医院获得性感染临床样本中病原体的检测。(源自:药品资讯网)
Recently, the Swiss pharmaceutical giant Roche announced that a cobas Cdiff Test for detecting Clostridium difficile and a cobas HSV-1 & HSV-2 Test for detecting herpes simplex virus (HSV-1, HSV-2) FDA approved 510 (k). These two kits run on the Roche cobas 4800 system and are flexible for the detection of pathogens in clinical-acquired specimens of sexually transmitted infections and hospital-acquired infections. (From: Drug Information Network)